TP53BP1 and neuroblastoma: Specifically pharmacological and genetic inhibition of SETD8 in NB cells induced a time- and dose-dependent increase in ɣH2AX or 53BP1 protein levels and an increased number of NB cells with > ɣH2AX or 53BP1 10 foci.